Back to search

Article

Cognate amino acid therapies provide preclinical benefit in 19 <i>C. elegans</i> models of ARS2 deficiency

2026-02-05

Abstract excerpt

<h4>ABSTRACT</h4> Mitochondrial aminoacyl-tRNA synthetases (mt-ARS) are essential mitochondrial translation machinery components that catalyze mitochondrial transfer RNAs (tRNAs) charging with their cognate amino acid. Although mt-ARS have a common biochemical function, patients with mt-ARS pathogenic variants commonly develop neurological disorders with varying phenotypes, severity spectrum, and age of onset. Co...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
74963fc2-ff59-51a3-9b0f-e8fe5da53540
DOI
10.64898/2026.02.03.703549
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Cognate amino acid therapies provide preclinical benefit in 19 <i>C. elegans</i> models of ARS2 deficiencyDOI 10.64898/2026.02.03.703549
Select a neighboring publication to make it the new centre.